Atlas Trials

Stage III Rectal Cancer AJCC v7

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage III Rectal Cancer AJCC v7

RecordFirmDate
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer (NCT03300544)National Cancer Institute (NCI)2019-05-14
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer (NCT03280277)OHSU Knight Cancer Institute2018-04-27
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery (NCT03317119)City of Hope Medical Center2018-04-11
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery (NCT03365882)SWOG Cancer Research Network2017-11-27
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer (NCT02921256)National Cancer Institute (NCI)2017-01-11
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy (NCT02381561)National Cancer Institute (NCI)2016-02-01
Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer (NCT00321685)National Cancer Institute (NCI)2006-07-25

Track Stage III Rectal Cancer AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.